颈部动脉夹层中的夹层动脉瘤:STOP-CAD研究启示
本研究为STOP-CAD国际多中心回顾性队列的二次分析,纳入4008例自发性颈部动脉夹层患者,评估夹层动脉瘤的危险因素及临床结局。结果显示13.6%基线存在夹层动脉瘤,7.5%随访中新发,多与结缔组织病、纤维肌发育不良和多血管夹层相关,但夹层动脉瘤与180天内缺血性卒中或颅内出血风险无关。
要点
- 颈部动脉夹层患者中夹层动脉瘤常见,多在诊断后6个月内出现。
- 结缔组织病、纤维肌发育不良和多血管夹层与夹层动脉瘤形成相关。
- 夹层动脉瘤未增加180天内缺血性卒中或颅内出血风险。
核心结论
- 夹层动脉瘤是颈部动脉夹层的常见表现,通常于诊断后6个月内发生,但与后续缺血性卒中或颅内出血风险无关。
研究设计与样本
- 国际多中心回顾性队列STOP-CAD的二次分析,纳入4008例自发性颈部动脉夹层患者。
主要发现
- 546例(13.6%)基线存在夹层动脉瘤,221/2938例(7.5%)随访中新发,其中172/221例(78.2%)在180天内检出。
- 夹层动脉瘤与结缔组织病(aOR 2.02,95%CI 1.22-3.36)、纤维肌发育不良(aOR 1.69,95%CI 1.28-2.25)和多血管夹层(aOR 1.53,95%CI 1.19-1.98)相关。
- 西班牙裔(aOR 0.64,95%CI 0.43-0.97)和缺血性卒中表现(aOR 0.41,95%CI 0.34-0.49)与夹层动脉瘤 odds 降低相关。
- 纤维肌发育不良与新发夹层动脉瘤相关(aOR 2.30,95%CI 1.52-3.49)。
- 夹层动脉瘤与180天内缺血性卒中(HR 0.71,95%CI 0.44-1.16;P=0.173)或颅内出血(HR 1.09,95%CI 0.42-2.84;P=0.86)无关。
临床怎么用
- 对颈部动脉夹层患者应关注夹层动脉瘤的形成,尤其合并结缔组织病、纤维肌发育不良或多血管夹层时。
- 夹层动脉瘤的存在不增加短期缺血或出血风险,抗栓治疗决策可主要依据其他临床因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cervical artery dissection (CeAD) may result in dissecting aneurysm (DA) formation. We aimed to characterize risk factors and clinical outcomes associated with DA in a large, international CeAD cohort. METHODS: We performed a secondary analysis of STOP-CAD (Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection), an international, multicenter, retrospective cohort. Patients with spontaneous CeAD were assessed for DA at baseline and de novo DA formation. Significant covariates in univariable analysis were included in multivariable regression models aiming to identify factors associated with DA formation. Logistic regression and Cox proportional hazards models evaluated the association of DA with ischemic and hemorrhagic outcomes. RESULTS: Among 4008 patients with CeAD, 546 (13.6%) had a DA at baseline, and 221/2938 (7.5%) patients developed a de novo DA during follow-up, of which 172/221 (78.2%) were detected in the first 180 days. Patients with DA had a mean age of 47 years, and 383 (49.9%) were women. Baseline or de novo DA was associated with a history of connective tissue disorder (adjusted odds ratio [aOR], 2.02 [95% CI, 1.22-3.36]), fibromuscular dysplasia (aOR, 1.69 [95% CI, 1.28-2.25]), and multiple vessel dissection (aOR, 1.53 [95% CI, 1.19-1.98]). Lower odds of DA were seen in Hispanic ethnicity (aOR, 0.64 [95% CI, 0.43-0.97]) and ischemic stroke presentation (aOR, 0.41 [95% CI, 0.34-0.49]). Fibromuscular dysplasia was associated with de novo DA formation (aOR, 2.30 [95% CI, 1.52-3.49]). DA was not associated with ischemic stroke (hazard ratio, 0.71 [95% CI, 0.44-1.16]; P=0.173) or intracranial hemorrhage (HR, 1.09 [95% CI, 0.42-2.84]; P=0.86) by day 180. CONCLUSIONS: DAs are relatively common manifestations of CeAD, typically occurring within 6 months of CeAD diagnosis. DA was not associated with an increased risk of subsequent ischemic stroke or intracranial hemorrhage.
引用
- Khan M, Keser Z, Shu L, et al. Dissecting Aneurysm in Cervical Artery Dissection: Insights From the STOP-CAD Study. Stroke. 2026. PMID: 41608793. doi:10.1161/STROKEAHA.125.054847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。